125 related articles for article (PubMed ID: 4730179)
1. Sensitizing ability and toxicity of iodoacetamide in radiotherapy of a C3H mouse mammary carcinoma.
Urano M; Tanaka N; Hayashi S
Br J Cancer; 1973 Aug; 28(2):190-3. PubMed ID: 4730179
[TBL] [Abstract][Full Text] [Related]
2. Reoxygenation in a C3H mouse mammary carcinoma. The importance of chronic rather than acute hypoxia.
Horsman MR; Grau C; Overgaard J
Acta Oncol; 1995; 34(3):325-8. PubMed ID: 7779417
[TBL] [Abstract][Full Text] [Related]
3. Radiosensitization of C3H mouse mammary tumours by a 2-nitroimidazole drug.
Sheldon PW; Foster JL; Fowler JF
Br J Cancer; 1974 Dec; 30(6):560-5. PubMed ID: 4451633
[TBL] [Abstract][Full Text] [Related]
4. Studies in radiosensitizing effects of misonidazole and SR-2508 on C3H/He mouse mammary tumors.
Ono K; Takahashi M; Nishidai T; Dodo Y; Shibamoto Y; Hiraoka M; Yukawa Y; Abe M
Radiat Med; 1984; 2(1):71-5. PubMed ID: 6242712
[TBL] [Abstract][Full Text] [Related]
5. [Effect of the hypoxic cell radiosensitizer,a dinitroimidazole derivative, on murine tumors].
Tanaka M; Nakajima T; Fukuda H; Kida A; Tsumura M; Sakashita M; Onoyama Y
Nihon Igaku Hoshasen Gakkai Zasshi; 1986 Dec; 46(12):1442-3. PubMed ID: 3822789
[No Abstract] [Full Text] [Related]
6. Radiosensitization of C3H mouse mammary tumours using fractionated doses of x rays with the drug Ro-07-0582.
Sheldon PW; Hill SA; Foster JL; Fowler JF
Br J Radiol; 1976 Jan; 49(577):76-80. PubMed ID: 1276579
[TBL] [Abstract][Full Text] [Related]
7. The influence of radiation dose on the magnitude and kinetics of reoxygenation in a C3H mammary carcinoma.
Grau C; Overgaard J
Radiat Res; 1990 Jun; 122(3):309-15. PubMed ID: 2356285
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of agents counteracting hypoxia in fractionated radiation regimes.
Stern S; Guichard M
Radiother Oncol; 1996 Nov; 41(2):143-9. PubMed ID: 9004358
[TBL] [Abstract][Full Text] [Related]
9. In situ tumour radiosensitization induced by clofibrate administration: single dose and fractionated studies.
Calais G; Hirst DG
Radiother Oncol; 1991 Oct; 22(2):99-103. PubMed ID: 1957008
[TBL] [Abstract][Full Text] [Related]
10. Optimum fractionation of the C3H mouse mammary carcinoma using x-rays, the hypoxic-cell radiosensitizer Ro-07-0582, or fast neutrons.
Fowler JF; Sheldon PW; Denekamp J; Field SB
Int J Radiat Oncol Biol Phys; 1976; 1(7-8):579-92. PubMed ID: 977399
[No Abstract] [Full Text] [Related]
11. In vivo radiosensitizing activity of a new fluorinated hypoxic cell radiosensitizer, KU-2285, in combination with radiation dose fractionation.
Sasai K; Fushiki M; Yukawa Y; Suyama S; Iwai H; Shibamoto Y; Nishimoto S; Takahashi M; Abe M
Int J Radiat Oncol Biol Phys; 1991 Oct; 21(5):1231-4. PubMed ID: 1938521
[TBL] [Abstract][Full Text] [Related]
12. Biological properties and response to x-rays of first-generation transplants of spontaneous mammary carcinomas in C3H mice.
Fowler JF; Sheldon PW; Begg AC; Hill SA; Smith AM
Int J Radiat Biol Relat Stud Phys Chem Med; 1975 May; 27(5):463-80. PubMed ID: 1080142
[TBL] [Abstract][Full Text] [Related]
13. Effect of docetaxel on the therapeutic ratio of fractionated radiotherapy in vivo.
Mason KA; Kishi K; Hunter N; Buchmiller L; Akimoto T; Komaki R; Milas L
Clin Cancer Res; 1999 Dec; 5(12):4191-8. PubMed ID: 10632360
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxic and radiosensitizing effects of hypoxic cell sensitizers on EMT6 mouse mammary tumour cells in vivo and in vitro.
Rockwell S
Br J Cancer Suppl; 1978 Jun; 3():212-5. PubMed ID: 277230
[TBL] [Abstract][Full Text] [Related]
15. Preclinical studies on how to deal with patient intolerance to nicotinamide and carbogen.
Horsman MR; Overgaard J
Radiother Oncol; 2004 Mar; 70(3):301-9. PubMed ID: 15064017
[TBL] [Abstract][Full Text] [Related]
16. The relationship between carbon monoxide breathing, tumour oxygenation and local tumour control in the C3H mammary carcinoma in vivo.
Grau C; Khalil AA; Nordsmark M; Horsman MR; Overgaard J
Br J Cancer; 1994 Jan; 69(1):50-7. PubMed ID: 8286210
[TBL] [Abstract][Full Text] [Related]
17. The demonstration of in vivo misonidazole tumour toxicity using post radiation hypoxia.
Gomer CJ; Johnson RJ; Hetzel FW; Lawrence G
Br J Cancer Suppl; 1978 Jun; 3():228-31. PubMed ID: 277234
[TBL] [Abstract][Full Text] [Related]
18. Metronidazole and fractionated radiotherapy of a murine tumor.
Stone HB
Int J Radiat Oncol Biol Phys; 1976; 1(11-12):1133-7. PubMed ID: 993090
[No Abstract] [Full Text] [Related]
19. Enhanced local tumour control after single or fractionated radiation treatment using the hypoxic cell radiosensitizer doranidazole.
Murata R; Tsujitani M; Horsman MR
Radiother Oncol; 2008 Jun; 87(3):331-8. PubMed ID: 18375007
[TBL] [Abstract][Full Text] [Related]
20. The influence of intracellular recovery and hypoxic cells on the radiation response of mammary tumours and skin in C3H mice.
Cheshire PJ; Lindop PJ
Br J Radiol; 1969 Mar; 42(495):215-23. PubMed ID: 5765697
[No Abstract] [Full Text] [Related]
[Next] [New Search]
